Back
America Movil SAB de CV Vs. Akero Therapeutics Industry Stock Comparison
Buy
55
AMX
America Movil SAB de CV
Last Price:
$17.24
Seasonality Move:
2.66%
Sell
50
AKRO
Akero Therapeutics
Last Price:
$54.29
Seasonality Move:
30.3%
Buy
55
America Movil SAB de CV (AMX)
is a Buy
Is America Movil SAB de CV a Buy, Sell or Hold?
-
The current America Movil SAB de CV [AMX] share price is $17.00. The Score for AMX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
AMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.03. The Score for AKRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMX Stock Price Chart
What is America Movil SAB de CV's stock price today?
-
The America Movil SAB de CV share price today is $17.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMX is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.03The current trend is moderately bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 48.51 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.94 - 17.48) | Sell |
Bollinger Bands (100): | (14.25 - 17.01) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.74 | Buy |
Relative Strength Index (14 RSI): | 62.21 | Buy |
Chaikin Money Flow: | 788305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.84 - 55.48) | Buy |
Bollinger Bands (100): | (40.11 - 52.17) | Buy |
AMX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.23 | Sell |
20-day SMA: | 17.15 | Sell |
50-day SMA: | 16.87 | Buy |
200-day SMA: | 15.53 | Buy |
8-day EMA: | 17.14 | Sell |
20-day EMA: | 17.12 | Sell |
50-day EMA: | 16.7 | Buy |
200-day EMA: | 16.07 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.55 | Sell |
20-day SMA: | 52.23 | Buy |
50-day SMA: | 45.56 | Buy |
200-day SMA: | 37.5 | Buy |
8-day EMA: | 54.31 | Sell |
20-day EMA: | 52.08 | Buy |
50-day EMA: | 47.87 | Buy |
200-day EMA: | 39.35 | Buy |
America Movil SAB de CV Earnings Growth & AMX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.02 per share, an increase this year of $0.78 per share, and an increase next year of $0.09 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
America Movil SAB de CV Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |